iFyber, LLC

Overview

iFyber is a preclinical contract research organization that works at the intersection of biology, chemistry, and materials science. The company offers contract research services on a fee basis to support client R&D initiatives.

Services

• Microbiology: antimicrobial efficacy testing (including AATCC Method 100), biofilm testing and models, and related antimicrobial and anti-biofilm methods such as zone of inhibition, MIC/MBC/MBEC, and time-kill assays.
• Cellular and tissue models: in vitro biocompatibility testing, 2D and 3D advanced cellular models, tissue-engineered and ex vivo models, and histology and imaging.
• LC-MS/MS analysis: LC-MS instrumentation, proteomics, extractables and leachables (E&L), metabolomics, and lipidomics.
• Immunological and molecular analysis: biomarker characterization, custom immunoassays, custom molecular assay development, DNA and RNA analysis and sequencing, and colorimetric and fluorometric assays.
• Materials characterization: techniques cited include X-ray diffraction, TGA/DSC, mechanical testing, DLS particle size distribution, porosity and surface area, elemental composition, and in vitro degradation and bioactivity assessment.

Areas of focus

iFyber references application areas including oral and dental, skin and health, wound care, implantable devices, orthopedic devices, and regenerative medicine.

Approach

iFyber describes a custom method development approach, with application-specific assays used during research and development to generate data for product design, verification, and manufacturing. Typical uses cited include early feasibility testing, building a case for regulatory discussions such as with the FDA, and providing data for peer-reviewed publications or whitepapers.

Location

Headquartered in Ithaca, New York.